CHCWM – Cancer & Hematology Centers of West Michigan

In the News

As the largest physician-owned oncology and hematology practice in Michigan, we are often in the news. See what we've been up to.
Join our LLS Light the Night Team!

The Leukemia & Lymphoma Society (LLS)’s Light the Night Fundraiser is next week Thursday, Oct. 1, and we would love for patients and families to join the CHCWM team! This year’s event is virtual, and while this may have its »

START Midwest physicians present at Virtual ESMO Congress

START Midwest’s Nehal Lakhani, MD, PhD, and Manish Sharma, MD, were granted oral presentations at the European Society for Medical Oncology (ESMO)’s Virtual 2020 Congress. The physicians’ presentations were two of the four “Investigational Immunotherapy” presentations selected to be shared. »

START Midwest physician published in ‘New England Journal of Medicine’

START Midwest physician Nehal Lakhani, MD, PhD, authored an article that was recently published on The New England Journal of Medicine’s website. The article titled “The Efficacy of Selpercatinib in RET-Altered Thyroid Cancers” details START Midwest’s former LIBRETTO-001 clinical trial, Read more »

CHC creates new Patient Experience role

Cancer and Hematology Centers of Western Michigan (CHC) is happy to announce that we are furthering our commitment to compassionate care with our new Patient Experience role. Patty Jereck, who has previously served as CHC’s Director of Nursing, will now Read more »

START Midwest study and physician featured on BioSpace

START Midwest’s ST101 (Sapience) clinical trial was recently featured on the website BioSpace, an online hub for Life Sciences news. The Phase I/II study is currently researching the use of ST-101, a peptide therapy, in adult patients with unresectable and Read more »

CHC physician Haritha Reddy, MD, published

Cancer & Hematology Centers of Western Michigan (CHC)’s Haritha Reddy, MD, has recently been published by Taylor & Francis Online. The article titled “Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors” examines immune checkpoint inhibitors Read more »

Page 4 of 9